Page 10716
The subject of Nicotinamide Riboside (NR) has been in the new a lot lately but is all the hype justified? Find out in this scientific article on Longecity by researcher Sven Bulterijs.
Researcher Sven Bulterijs has published a scientific article about nicotinamide riboside, how it works and looking at the data behind this recently popular supplement. So does it live up to the hype? Why not check it out and decide yourself.
“The first article in my new science column takes a look at a special vitamin B3 derivative called nicotinamide riboside that was shown to slightly extend mouse lifespan.”
Nov 19, 2016
AI Learns Things That Humans Didn’t Teach It
Posted by Elmar Arunov in categories: information science, robotics/AI
In Brief:
- Researchers have created a heuristically trained neural network that outperformed conventional machine learning algorithms by 160 percent and its own training by 9 percent.
- This new teaching method could enable AI to make correct classifications of data that’s previously unknown or unclassified, learning information beyond its data set.
Machine learning technology in neural networks has been pushing artificial intelligence (AI) development to new heights. Most AI systems learn to do things using a set of labelled data provided by their human programmers. Parham Aarabi and Wenzhi Guo, engineers from the University of Toronto, Canada have taken machine learning to a different level, developing an algorithm that can learn things on its own, going beyond its training.
Read more
Nov 19, 2016
These geniuses sent a text message using only vinegar and glass cleaner and it is mesmerizing
Posted by Shane Hinshaw in category: futurism
Nov 19, 2016
Italy’s Banks Are in a Slow-Motion Crisis. And Europe May Pay. — By Peter S. Goodman | The New York Times
Posted by Odette Bohr Dienel in categories: economics, finance, policy
“Among policy makers alert for signs of the next financial disaster, Italy’s mountain of uncollectable bank debt is a subject discussed in tones ordinarily reserved for piles of plutonium.”
Nov 19, 2016
Venture Capital Firm Navigates Uncharted Course to Success — By Michael J. de la Merced | The New York Times
Posted by Odette Bohr Dienel in categories: business, finance
Nov 19, 2016
Nanoantenna Changes Direction of Light and the Prospects of Optical Computing
Posted by Klaus Baldauf in category: computing
Nov 19, 2016
Reviving optimism for regenerative medicine
Posted by Steve Hill in categories: bioengineering, biotech/medical, economics, life extension
Progress in real science is steady, follows proper methodology and respects engineering safety. We live in an amazing world where medical progress is advancing rapidly, sadly we also have those willing to jump the gun hawking unproven experimental therapies without sufficient data.
Unproven therapies and people jumping the gun to make a quick buck are a plague in the aging research field. Real science is slow and methodical but ultimately gets results that ensure safe therapies can be deployed in the healthcare arena. At Lifespan.io we are passionate about supporting the progress of science that is conducted properly.
“The life science community should embrace the discrediting of unproven therapies promoted without data for economic gain, and instead focus on the promise of research held to the highest standards.”
Continue reading “Reviving optimism for regenerative medicine” »
